Xylyx Bio announces exclusive license agreement with Vanderbilt University for donor organ rehabilitation asset
Xylyx Bio, a regenerative medicine company developing innovative solutions for tissue and organ repair, today announced entry into an exclusive license agreement with Vanderbilt University for the rights to a xenogeneic cross-circulation platform that restores damaged donor organs to transplant condition. The…
New drug class prevents key ageing mechanism in organ transplants
A novel study has shown that Senolytics, a new class of drugs, have the potential to prevent the transfer of senescence, a key mechanism of ageing, in recipients of older donor organs. The pioneering research, presented today at the European…
Lung transplant restores life for 16-year-old boy, marking a remarkable medical triumph at Medica Superspecialty Hospital
The tale of Swapnil Biswas, a 16-year-old boy from Barasat, West Bengal, is a testament to medical innovation and resilience. After accidentally ingesting paraquat, a herbicide known for its lethal toxicity, Swapnil was left battling severe respiratory distress. Despite the…
